Manufacturer
17 recalls in our database name Actavis Inc as the manufacturing or recalling firm.
Of the 17 recalls from Actavis Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (18%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Actavis Inc is recalling specific lots of Levofloxacin Ophthalmic Solution because the product failed impurity specifications for a related compound.
Actavis Inc is recalling specific lots of Glipizide extended-release tablets because they failed to meet dissolution specifications at the 10-hour testing point.
Actavis Inc is recalling specific lots of Albuterol Sulfate Inhalation Solution because the product failed impurity specifications for a known degradant.
Actavis Inc is recalling 672 bottles of Acetasol HC otic solution because stability testing showed an out-of-specification related compound at the 12-month time point.
Actavis Inc. is recalling 2,543 bottles of Hydrocortisone and acetic acid otic solution because stability testing showed out-of-specification results for a related compound.
Actavis Inc is recalling specific lots of Glipizide 2.5 mg Extended-Release tablets because they failed to meet dissolution specifications.
Actavis Inc is recalling Dextroamphetamine Sulfate Extended-Release Capsules because they failed to meet dissolution specifications. The recall covers 8,062 units distributed nationwide.
Actavis Inc is recalling Lutera birth control tablets because the packs were distributed with out-dated package inserts.
Actavis Inc. is voluntarily recalling 29,405 cartons of Vancomycin Hydrochloride Capsules, USP, 250 mg, because the drug was found to be subpotent.
Actavis Inc. is voluntarily recalling 51,472 cartons of Vancomycin Hydrochloride Capsules, USP, 125 mg, because the drug is subpotent.
Actavis Inc. is voluntarily recalling 46,676 cartons of Vancomycin Hydrochloride Capsules, USP, 250 mg, because the drug is subpotent.
Actavis Inc is voluntarily recalling 26,663 cartons of Vancomycin Hydrochloride Capsules because the drug was found to be subpotent.
Actavis Inc is recalling 6,913 packages of Vancomycin Hydrochloride Capsules because the drug is subpotent. The recall covers distribution across the United States.
Actavis is recalling 99 cartons of Trelstar 11.25 mg due to a labeling error where the vial was marked 3.75 mg. The product was distributed nationwide and in Puerto Rico.
Actavis Inc is recalling 6,540 bottles of Diclofenac Sodium and Misoprostol tablets because some tablets are broken.
Actavis Inc is recalling Bupropion Hydrochloride Extended-Release Tablets because they failed stability testing for dissolution specifications at 18 months.
Actavis Inc is recalling 15,132 bottles of BuPROPion Hydrochloride Extended-Release Tablets (XL) 300 mg because dissolution test results exceeded approved limits.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Actavis
pharmaceutical company
Source: Wikidata (Q343204), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.